Both NT-pro BNP and cTNI were shown to be increased in patients with non-cardiac diseases, including pulmonary hypertension, chronic obstructive pulmonary disease (COPD), renal dysfunction and sepsis [13]. Here, NPPB is linked to chronic obstructive pulmonary disease.